Danaher Corp
Change company Symbol lookup
Select an option...
DHR Danaher Corp
WDAY Workday Inc
BNOX Bionomics Ltd
NRDY Nerdy Inc
KEY KeyCorp
AMPX Amprius Technologies Inc
TPC Tutor Perini Corp
LTRN Lantern Pharma Inc
JGGC Jaguar Global Growth Corporation I
WHG Westwood Holdings Group Inc
Go

Health Care : Life Sciences Tools & Services | Large Cap Blend
Company profile

Danaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s segments include Biotechnology, which includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables and services; Life Sciences segment, which offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines; Diagnostics segment that offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease, and Environmental & Applied Solutions segment, which offers products and services that help protect precious resources and keep global food and water supplies safe.

Closing Price
$247.19
Day's Change
-0.25 (-0.10%)
Bid
--
Ask
--
B/A Size
--
Day's High
249.97
Day's Low
246.89
Volume
(Average)
Volume:
2,341,925

10-day average volume:
2,465,449
2,341,925

DHR's position in the Life Sciences Tools & Services industry

Industry PeersDHRMRKTMOABTAMGN

Summary

Company ProfileDanaher Corporation designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company’s segments include Biotechnology, which includes the...
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products. The...
Go to MRK summary
Thermo Fisher Scientific Inc. is engaged in serving science. The Company’s Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical...
Go to TMO summary
Abbott Laboratories is a global healthcare company. The Company’s portfolio of technologies spans the spectrum of healthcare, with businesses and products in diagnostics, medical devices, nutritional...
Go to ABT summary
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company’s marketed...
Go to AMGN summary
52-Week Change

VS. INDUSTRY
-7.16%
20.19%
-2.86%
-0.61%
17.25%
Market Cap

VS. INDUSTRY
$182.7B
$263.7B
$192.3B
$165.8B
$143.9B
Beta

VS. INDUSTRY
0.8
0.4
0.8
0.7
0.6
Dividend Yield

VS. INDUSTRY
0.44%
2.81%
0.28%
2.14%
3.17%
P/E (TTM, GAAP)

VS. INDUSTRY
29.03x
85.29x
34.05x
32.48x
18.13x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$30.4B
$58.3B
$43.5B
$40.2B
$26.6B
Profit Margin

VS. INDUSTRY
20.95%
5.36%
13.48%
12.83%
30.02%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
25.70%
25.61%
23.62%
30.55%
1.96%
Revenue Growth (TTM)

VS. INDUSTRY
-1.49%
2.00%
1.64%
-11.68%
0.75%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.